Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2020
Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma.
Journal: Immunotherapy
Published: September 08, 2017
What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
Journal: Current treatment options in oncology
Published: March 01, 2017
Showing 1-3 of 3
Last Updated: 09/26/2026